Author: Hippocratic Post

Disruption and ongoing instability as Australians navigate the coronavirus (COVID-19) pandemic is weighing heavily on people with a mood disorder such as depression or bipolar disorder, new research shows. Researchers at the University of Melbourne and Swinburne University of Technology surveyed almost 4,500 people in April during the COVID-19 lockdown, finding that respondents with a mood disorder […]

Read More… from Some people with mood disorders struggling amid pandemic: study

A new study of twins and triplets shows how our close social relationships are vital in how we cope with the upheaval of the coronavirus (COVID-19) pandemic. The study involved over 3500 adult twins and triplets from across Australia at the height of initial social lockdown measures.  Called TRACKERR, the Twins Research Australia COVID-19 Knowledge, Experience, Reaction and Resilience study […]

Read More… from Strong close relationships key in coping with pandemic, twin study shows

A saliva based test for COVID-19 providing results directly to patients in minutes is being developed as a result of a new collaboration between Luas Diagnostics and the University of Birmingham. Luas Diagnostics of Guildford, Surrey, has signed a Memorandum of Understanding with the University of Birmingham to collaborate on the development of a rapid, […]

Read More… from Saliva based rapid test for COVID-19 antigen

An average of 3,399 patients per week missed out on urgent and routine referrals during lockdown, according to the Taskforce for Lung Health­. New analysis by the Taskforce for Lung Health reveals that people in urgent need of support for respiratory problems saw a large drop in levels of care during the lockdown. Crucially, outcomes […]

Read More… from Referrals of urgent care lung conditions drop by up to 70%

Ambitious annual target on HIV treatment could be achieved for equivalent of just one month of global spend on HIV drugs The Make Medicines Affordable campaign is calling for a widespread switch from patented to generic HIV drugs so that at least 95% of those living with HIV globally would be able to receive treatment. […]

Read More… from HIV treatment targets in sight